✦ LIBER ✦

Recombinant leukocyte a interferon with doxorubicin. A phase I study in advanced solid neoplasms and implications for hepatocellular carcinoma

✍ Scribed by E. T. Creagan; H. J. Long; S. Frytak; C. G. Moertel

Publisher: John Wiley and Sons
Year: 1988
Tongue: English
Weight: 422 KB
Volume: 61
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19880101)61:1<19::aid-cncr2820610105>3.0.co;2-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase I study of recombinant leukocyte a

Phase I study of recombinant leukocyte a interferon (IFN-α2A, roferon-A) with doxorubicin in advanced malignant disease

✍ Edward T. Creagan; Stephen Frytak; Harry J. Long; Larry K. Kvols 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 312 KB 👁 1 views

A phase I clinical and pharmacologic stu

A phase I clinical and pharmacologic study of a carboplatin and irinotecan regimen combined with recombinant human granulocyte-colony stimulating factor in the treatment of patients with advanced nonsmall cell lung carcinoma

✍ Hiroaki Okamoto; Akira Nagatomo; Hideo Kunitoh; Hiroshi Kunikane; Koshiro Watana 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 84 KB 👁 2 views

BACKGROUND. This Phase I study was designed to determine the toxicity and efficacy of a carboplatin and irinotecan (CPT-11) regimen with recombinant human granulocyte colony-stimulating factor (rhG-CSF) support for patients with advanced nonsmall cell lung carcinoma. ## METHODS. Treatment consist

Phase I study to evaluate multiple regim

Phase I study to evaluate multiple regimens of intravenous 5-fluorouracil administered in combination with weekly gemcitabine in patients with advanced solid tumors : A potential broadly active regimen for advanced solid tumor malignancies

✍ Sridhar Mani; Nicholas J. Vogelzang; Donna Bertucci; Walter M. Stadler; Richard 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 95 KB 👁 2 views

A randomized, controlled phase III study

A randomized, controlled phase III study of cyclophosphamide, doxorubicin, and vincristine with etoposide (CAV-E) or teniposide (CAV-T), followed by recombinant interferon-α maintenance therapy or observation, in small cell lung carcinoma patients with complete responses

✍ Diego Tummarello; Davide Mari; Francesco Graziano; Pierpaolo Isidori; Gianluigi 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 109 KB 👁 2 views

BACKGROUND. Studies of chemotherapy for

5-Fluorouracil and levofolinic acid with

5-Fluorouracil and levofolinic acid with or without recombinant interferon-2b in patients with advanced colorectal carcinoma : A randomized multicenter study with stratification for tumor burden and liver involvement by the Southern Italy Oncology Group

✍ Giuseppe Colucci; Evaristo Maiello; Vittorio Gebbia; Francesco Giuliani; Giusepp 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 120 KB 👁 1 views

## Background: The objectives of the current study were: 1) to verify whether the addition of modulating low doses of interferon-2b (ifn) to 5-fluorouracil (5-fu) and levofolinic acid (1-fa) could improve clinical results in patients with advanced colorectal carcinoma; and 2) to evaluate the role o

Evaluation of 96-hour infusion fluoroura

Evaluation of 96-hour infusion fluorouracil plus cisplatin in combination with alpha interferon for patients with advanced squamous cell carcinoma of the head and neck. A southwest oncology group study

✍ Maha Hussain; Jacqueline Benedetti; Roy E. Smith; Gladys I. Rodriguez; David Sch 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 456 KB 👁 2 views